Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
Buprenorphine for Individuals in Jail
for
Opioid Use Disorder
Location: Baltimore MD
Sponsor: Friends Research Institute, Inc.
Sex: All
Age: 18+
Code: NCT06306443
Phase 3, Recruiting
Physician- and Patient-based Barriers to NGS Testing
for
Metastatic Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18+
Code: NCT07209176
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Location: York PA, Bethesda MD, Rochester NY, Charlotte NC,
Sponsor: Tempus AI
Sex: All
Age: 0+
Code: NCT07154823
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Watertown MA, Springfield MA, Hartsdale NY, Brooklyn NY,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Montreal, Philadelphia PA, Baltimore MD,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Cancer
Location: The Bronx NY, New Brunswick NJ, Morristown NJ,
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT07057791
Phase 2, Recruiting
Post-Concussion Musculoskeletal Injury Risks
for
Musculoskeletal Injury
Location: Bethesda MD, Athens GA
Sponsor: Walter Reed National Military Medical Center
Sex: All
Age: 18 - 40
Code: NCT05122728
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
for
Urothelial Cancer
Location: New York NY, Montreal, Baltimore MD, Ottawa,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07106762
Phase 2, Phase 3, Recruiting
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
for
Adenocarcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06041503
Phase 2, Recruiting
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
for
HIV-1
Location: The Bronx NY, Baltimore MD, Jacksonville FL, Houston TX,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0
Code: NCT06517693
Phase 1, Recruiting
A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects
for
Healthy Subjects, Exosome, Targeted Therapy
Location: Baltimore MD
Sponsor: Shine-On Biomedical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07219940
Phase 1, Recruiting
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
for
Post Operative Pain
Location: Manchester NH, Annapolis MD, Orlando FL,
Sponsor: AtriCure, Inc.
Sex: All
Age: 12+
Code: NCT05110989
Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study